Inventor · disambiguated record
Ole Baadsgaard
Also filed as: BAADSGAARD D M SC OLE · BAADSGAARD OLE
31 granted patents·21 pending applications·753 citations·filing 2002–2025
97Inventor score
Files withGENMAB AS32CORMORANT PHARMACEUTICALS AB4TEELING JESSICA3DE GOEIJ BART2MEMORIAL SLOAN KETTERING CANCER CENTER2
Top patents by PatentIndex Score
52 records- 0198US7153507B2Human antibodies specific for interleukin 15 (IL-15)GENMAB AS·Filed 2002·Granted Dec 26, 2006·367 cites·32 claims
- 0294US9040050B2Combination treatment of CD38-expressing tumorsVAN DE WINKEL JAN·Filed 2007·Granted May 26, 2015·39 cites·68 claims
- 0394US7595378B2Human monoclonal antibodies to epidermal growth factor receptor (EGFR)GENMAB AS·Filed 2002·Granted Sep 29, 2009·64 cites·14 claims
- 0494US7438907B2Human monoclonal antibodies against CD25GENMAB AS·Filed 2003·Granted Oct 21, 2008·50 cites·31 claims
- 0593US7282568B2Human monoclonal antibodies against interleukin 8 (IL-8)GENMAB AS·Filed 2003·Granted Oct 16, 2007·39 cites·23 claims
- 0692US11339215B2Methods of treating cancer with human monoclonal antibodies against interleukin 8 (IL-8)CORMORANT PHARMACEUTICALS AB·Filed 2019·Granted May 24, 2022·4 cites·19 claims
- 0790US9862769B2Monoclonal antibodies against HER2DE GOEIJ BART·Filed 2011·Granted Jan 9, 2018·16 cites·42 claims
- 0890US9714294B2Monoclonal antibodies against HER2 epitopeDE GOEIJ BART·Filed 2011·Granted Jul 25, 2017·17 cites·43 claims
- 0990US9714297B2Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2015·Granted Jul 25, 2017·9 cites·29 claims
- 1090US9150658B2Human antibodies against tissue factor and methods of use thereofVERPLOEGEN SANDRA·Filed 2009·Granted Oct 6, 2015·20 cites·43 claims
- 1189US8529902B2Human monoclonal antibodies against CD20TEELING JESSICA·Filed 2003·Granted Sep 10, 2013·36 cites·5 claims
- 1288US7622559B2Human monoclonal antibodies against interleukin 8 (IL-8)GENMAB AS·Filed 2007·Granted Nov 24, 2009·7 cites·15 claims
- 1387US8105588B2Human monoclonal antibodies against interleukin 8 (IL-8)TEELING JESSICA·Filed 2009·Granted Jan 31, 2012·7 cites·22 claims
- 1486US8182812B2Human monoclonal antibodies against CD25SCHUURMAN JANINE·Filed 2008·Granted May 22, 2012·7 cites·17 claims
- 1585US11046771B2Monoclonal antibodies against HER2GENMAB AS·Filed 2017·Granted Jun 29, 2021·2 cites·23 claims
- 1685US7329405B2Human antibodies specific for interleukin 15 (IL-15)GENMAB AS·Filed 2003·Granted Feb 12, 2008·11 cites·10 claims
- 1785US7247304B2Methods of treating using anti-IL-15 antibodiesGENMAB AS·Filed 2003·Granted Jul 24, 2007·21 cites·18 claims
- 1884US9598493B2Human monoclonal antibodies against CD25GENMAB AS·Filed 2015·Granted Mar 21, 2017·3 cites·11 claims
- 1984US8961968B2Human monoclonal antibodies against CD25SCHUURMAN JANINE·Filed 2012·Granted Feb 24, 2015·5 cites·8 claims
- 2084US8603469B2Methods of treating cancer with human monoclonal antibodies against interleukin 8TEELING JESSICA·Filed 2011·Granted Dec 10, 2013·5 cites·23 claims
- 2184US7585961B2Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)GENMAB AS·Filed 2007·Granted Sep 8, 2009·5 cites·22 claims
- 2283US10253093B2Human monoclonal antibodies against interleukin 8 (IL-8)CORMORANT PHARMACEUTICALS AB·Filed 2018·Granted Apr 9, 2019·2 cites·15 claims
- 2382US10066012B2Human monoclonal antibodies against interleukin 8 (IL-8)CORMORANT PHARMACEUTICALS AB·Filed 2016·Granted Sep 4, 2018·2 cites·15 claims
- 2482US2024165226A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2023·Application pending·0 cites
- 2582US2023416403A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2022·Application pending·0 cites
- 2680US11091553B2Monoclonal antibodies against HER2GENMAB AS·Filed 2017·Granted Aug 17, 2021·1 cites·20 claims
- 2780US2023042255A1Human monoclonal antibodies against interleukin 8 (il-8)CORMORANT PHARMACEUTICALS AB·Filed 2022·Application pending·0 cites
- 2879US10793640B2Monoclonal antibodies against HER2 epitopeGENMAB AS·Filed 2017·Granted Oct 6, 2020·1 cites·38 claims
- 2979US8586041B2Human monoclonal antibodies to epidermal growth factor receptor (EGFR)VAN DE WINKEL JAN G J·Filed 2009·Granted Nov 19, 2013·5 cites·23 claims
- 3079US2025340669A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2025·Application pending·0 cites
- 3177US9458236B2Human monoclonal antibodies to epidermal growth factor receptor (EGFR)GENMAB AS·Filed 2013·Granted Oct 4, 2016·2 cites·20 claims
- 3276US2024415990A1Use of anti-b7h3 antibodies for treating cancer in the central nervous systemMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 3374US7597892B2Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)GENMAB AS·Filed 2007·Granted Oct 6, 2009·1 cites·13 claims
- 3473US2022169738A1Monoclonal antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 3573US2020114000A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2019·Application pending·0 cites
- 3673US2021107985A1Human monoclonal antibodies against cd25GENMAB AS·Filed 2020·Application pending·0 cites
- 3772US2015231235A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2014·Application pending·0 cites
- 3871US9428582B2Method of treating rash in patients undergoing anti-EGFR therapyEDVARDSEN KLAUS·Filed 2007·Granted Aug 30, 2016·3 cites·34 claims
- 3969US9309315B2Therapy with CD4 binding peptides and radiationPARREN PAUL·Filed 2006·Granted Apr 12, 2016·2 cites·34 claims
- 4069US2021171657A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2020·Application pending·0 cites
- 4168US2020317799A1Human Monoclonal Antibodies Against CD20GENMAB AS·Filed 2019·Application pending·0 cites
- 4266US10703818B2Human monoclonal antibodies against CD25GENMAB AS·Filed 2017·Granted Jul 7, 2020·0 cites·14 claims
- 4365US2021122830A1Monoclonal antibodies against her2 epitopeGENMAB AS·Filed 2020·Application pending·0 cites
- 4465US2014170156A1Human monoclonal antibodies against interleukin 8 (il-8)GENMAB AS·Filed 2013·Application pending·0 cites
- 4564US2019169311A1Human Antibodies Against Tissue Factor and Methods of Use ThereofGENMAB AS·Filed 2018·Application pending·0 cites
- 4661US2018044431A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2017·Application pending·0 cites
- 4760US2020197546A1Use of anti-b7h3 antibodies for treating cancer in the central nervous systemMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Application pending·0 cites
- 4858US2009155204A1Methods for treating disorders involving monocytesGENMAB AS·Filed 2008·Application pending·0 cites
- 4955US2014093454A1Human Monoclonal Antibodies Against CD20GENMAB AS·Filed 2013·Application pending·0 cites
- 5054US2005123542A1Methods for treating disorders involving monocytesGENMAB AS·Filed 2004·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →